Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder

Clinical trial NCT02673047 · COMPLETED

Trial details

NCT number: NCT02673047
Sponsor: Allergan
Status: COMPLETED
Study type: OBSERVATIONAL

Urinary Bladder, Overactive Urinary Bladder, Neurogenic

Start date: 2016-02-01
Primary completion: 2016-08-01
Enrollment: 474

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.